Table of Contents Chapter 1 Overview of Peptide Antibiotics 1.1 Definition of Peptide Antibiotics in This Report 1.2 Commercial Types of Peptide Antibiotics 1.2.1 Ribosomal Synthesized Peptide Antibiotics 1.2.2 Non-Ribosomally Synthesized Peptide Antibiotics 1.3 Downstream Application of Peptide Antibiotics 1.3.1 Pharma & Healthcare 1.3.2 Food Industry 1.3.3 Commodities 1.3.4 Other 1.4 Development History of Peptide Antibiotics 1.5 Market Status and Trend of Peptide Antibiotics 2013-2023 1.5.1 China Peptide Antibiotics Market Status and Trend 2013-2023 1.5.2 Regional Peptide Antibiotics Market Status and Trend 2013-2023 Chapter 2 China Market Status and Forecast by Regions 2.1 Market Status of Peptide Antibiotics in China 2013-2017 2.2 Consumption Market of Peptide Antibiotics in China by Regions 2.2.1 Consumption Volume of Peptide Antibiotics in China by Regions 2.2.2 Revenue of Peptide Antibiotics in China by Regions 2.3 Market Analysis of Peptide Antibiotics in China by Regions 2.3.1 Market Analysis of Peptide Antibiotics in North China 2013-2017 2.3.2 Market Analysis of Peptide Antibiotics in Northeast China 2013-2017 2.3.3 Market Analysis of Peptide Antibiotics in East China 2013-2017 2.3.4 Market Analysis of Peptide Antibiotics in Central & South China 2013-2017 2.3.5 Market Analysis of Peptide Antibiotics in Southwest China 2013-2017 2.3.6 Market Analysis of Peptide Antibiotics in Northwest China 2013-2017 2.4 Market Development Forecast of Peptide Antibiotics in China 2018-2023 2.4.1 Market Development Forecast of Peptide Antibiotics in China 2018-2023 2.4.2 Market Development Forecast of Peptide Antibiotics by Regions 2018-2023 Chapter 3 China Market Status and Forecast by Types 3.1 Whole China Market Status by Types 3.1.1 Consumption Volume of Peptide Antibiotics in China by Types 3.1.2 Revenue of Peptide Antibiotics in China by Types 3.2 China Market Status by Types in Major Countries 3.2.1 Market Status by Types in North China 3.2.2 Market Status by Types in Northeast China 3.2.3 Market Status by Types in East China 3.2.4 Market Status by Types in Central & South China 3.2.5 Market Status by Types in Southwest China 3.2.6 Market Status by Types in Northwest China 3.3 Market Forecast of Peptide Antibiotics in China by Types Chapter 4 China Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Peptide Antibiotics in China by Downstream Industry 4.2 Demand Volume of Peptide Antibiotics by Downstream Industry in Major Countries 4.2.1 Demand Volume of Peptide Antibiotics by Downstream Industry in North China 4.2.2 Demand Volume of Peptide Antibiotics by Downstream Industry in Northeast China 4.2.3 Demand Volume of Peptide Antibiotics by Downstream Industry in East China 4.2.4 Demand Volume of Peptide Antibiotics by Downstream Industry in Central & South China 4.2.5 Demand Volume of Peptide Antibiotics by Downstream Industry in Southwest China 4.2.6 Demand Volume of Peptide Antibiotics by Downstream Industry in Northwest China 4.3 Market Forecast of Peptide Antibiotics in China by Downstream Industry Chapter 5 Market Driving Factor Analysis of Peptide Antibiotics 5.1 China Economy Situation and Trend Overview 5.2 Peptide Antibiotics Downstream Industry Situation and Trend Overview Chapter 6 Peptide Antibiotics Market Competition Status by Major Players in China 6.1 Sales Volume of Peptide Antibiotics in China by Major Players 6.2 Revenue of Peptide Antibiotics in China by Major Players 6.3 Basic Information of Peptide Antibiotics by Major Players 6.3.1 Headquarters Location and Established Time of Peptide Antibiotics Major Players 6.3.2 Employees and Revenue Level of Peptide Antibiotics Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Peptide Antibiotics Major Manufacturers Introduction and Market Data 7.1 Pfizer 7.1.1 Company profile 7.1.2 Representative Peptide Antibiotics Product 7.1.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Pfizer 7.2 Novartis 7.2.1 Company profile 7.2.2 Representative Peptide Antibiotics Product 7.2.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Novartis 7.3 GlaxoSmithKline 7.3.1 Company profile 7.3.2 Representative Peptide Antibiotics Product 7.3.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 7.4 Eli Lilly 7.4.1 Company profile 7.4.2 Representative Peptide Antibiotics Product 7.4.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Eli Lilly 7.5 Theravance 7.5.1 Company profile 7.5.2 Representative Peptide Antibiotics Product 7.5.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Theravance 7.6 Vicuron Pharmaceuticals 7.6.1 Company profile 7.6.2 Representative Peptide Antibiotics Product 7.6.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Vicuron Pharmaceuticals 7.7 Savara Pharmaceuticals 7.7.1 Company profile 7.7.2 Representative Peptide Antibiotics Product 7.7.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Savara Pharmaceuticals 7.8 AMP Therapeutics 7.8.1 Company profile 7.8.2 Representative Peptide Antibiotics Product 7.8.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of AMP Therapeutics 7.9 Hospira 7.9.1 Company profile 7.9.2 Representative Peptide Antibiotics Product 7.9.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Hospira 7.10 Kasten 7.10.1 Company profile 7.10.2 Representative Peptide Antibiotics Product 7.10.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Kasten 7.11 Madam Therapeutics 7.11.1 Company profile 7.11.2 Representative Peptide Antibiotics Product 7.11.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Madam Therapeutics 7.12 Phosphagenics 7.12.1 Company profile 7.12.2 Representative Peptide Antibiotics Product 7.12.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Phosphagenics 7.13 Pacgen Life Science Corporation 7.13.1 Company profile 7.13.2 Representative Peptide Antibiotics Product 7.13.3 Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Pacgen Life Science Corporation Chapter 8 Upstream and Downstream Market Analysis of Peptide Antibiotics 8.1 Industry Chain of Peptide Antibiotics 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Peptide Antibiotics 9.1 Cost Structure Analysis of Peptide Antibiotics 9.2 Raw Materials Cost Analysis of Peptide Antibiotics 9.3 Labor Cost Analysis of Peptide Antibiotics 9.4 Manufacturing Expenses Analysis of Peptide Antibiotics Chapter 10 Marketing Status Analysis of Peptide Antibiotics 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Ribosomal Synthesized Peptide Antibiotics Table Advantage and Disadvantage of Non-Ribosomally Synthesized Peptide Antibiotics Table Consumption Volume of Peptide Antibiotics in China by Regions 2013-2017 Table Revenue of Peptide Antibiotics in China by Regions 2013-2017 Table Consumption Volume of Peptide Antibiotics in China by Regions 2018-2023 Table Revenue of Peptide Antibiotics in China by Regions 2018-2023 Table Consumption Volume of Peptide Antibiotics in China by Types 2013-2017 Table Revenue of Peptide Antibiotics in China by Types 2013-2017 Table Consumption Volume of Peptide Antibiotics by Types in North China 2013-2017 Table Consumption Volume of Peptide Antibiotics by Types in Northeast China 2013-2017 Table Consumption Volume of Peptide Antibiotics by Types in East China 2013-2017 Table Consumption Volume of Peptide Antibiotics by Types in Central & South China 2013-2017 Table Consumption Volume of Peptide Antibiotics by Types in Southwest China 2013-2017 Table Consumption Volume of Peptide Antibiotics by Types in Northwest China 2013-2017 Table Consumption Volume Forecast of Peptide Antibiotics in China by Types 2018-2023 Table Revenue Forecast of Peptide Antibiotics in China by Types 2018-2023 Table Demand Volume of Peptide Antibiotics in China by Downstream Industry 2013-2017 Table Demand Volume of Peptide Antibiotics by Downstream Industry in North China 2013-2017 Table Demand Volume of Peptide Antibiotics by Downstream Industry in Northeast China 2013-2017 Table Demand Volume of Peptide Antibiotics by Downstream Industry in East China 2013-2017 Table Demand Volume of Peptide Antibiotics by Downstream Industry in Central & South China 2013-2017 Table Demand Volume of Peptide Antibiotics by Downstream Industry in Southwest China 2013-2017 Table Demand Volume of Peptide Antibiotics by Downstream Industry in Northwest China 2013-2017 Table Demand Volume Forecast of Peptide Antibiotics in China by Downstream Industry 2018-2023 Table Sales Volume of Peptide Antibiotics in China by Major Players 2013-2017 Table Revenue of Peptide Antibiotics in China by Major Players 2013-2017 Table Headquarters Location and Established Time of Peptide Antibiotics Major Players Table Employees and Revenue Level of Peptide Antibiotics Major Players Table Representative Peptide Antibiotics Product One of Pfizer Table Representative Peptide Antibiotics Product Two of Pfizer Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Peptide Antibiotics Product One of Novartis Table Representative Peptide Antibiotics Product Two of Novartis Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Novartis 2013-2017 Table Representative Peptide Antibiotics Product One of GlaxoSmithKline Table Representative Peptide Antibiotics Product Two of GlaxoSmithKline Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2013-2017 Table Representative Peptide Antibiotics Product One of Eli Lilly Table Representative Peptide Antibiotics Product Two of Eli Lilly Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Eli Lilly 2013-2017 Table Representative Peptide Antibiotics Product One of Theravance Table Representative Peptide Antibiotics Product Two of Theravance Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Theravance 2013-2017 Table Representative Peptide Antibiotics Product One of Vicuron Pharmaceuticals Table Representative Peptide Antibiotics Product Two of Vicuron Pharmaceuticals Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Vicuron Pharmaceuticals 2013-2017 Table Representative Peptide Antibiotics Product One of Savara Pharmaceuticals Table Representative Peptide Antibiotics Product Two of Savara Pharmaceuticals Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Savara Pharmaceuticals 2013-2017 Table Representative Peptide Antibiotics Product One of AMP Therapeutics Table Representative Peptide Antibiotics Product Two of AMP Therapeutics Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of AMP Therapeutics 2013-2017 Table Representative Peptide Antibiotics Product One of Hospira Table Representative Peptide Antibiotics Product Two of Hospira Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Hospira 2013-2017 Table Representative Peptide Antibiotics Product One of Kasten Table Representative Peptide Antibiotics Product Two of Kasten Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Kasten 2013-2017 Table Representative Peptide Antibiotics Product One of Madam Therapeutics Table Representative Peptide Antibiotics Product Two of Madam Therapeutics Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Madam Therapeutics 2013-2017 Table Representative Peptide Antibiotics Product One of Phosphagenics Table Representative Peptide Antibiotics Product Two of Phosphagenics Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Phosphagenics 2013-2017 Table Representative Peptide Antibiotics Product One of Pacgen Life Science Corporation Table Representative Peptide Antibiotics Product Two of Pacgen Life Science Corporation Table Peptide Antibiotics Sales, Revenue, Price and Gross Margin of Pacgen Life Science Corporation 2013-2017